ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of ...
… but our independent journalism isn’t free to produce. Help us keep it this way with a tax-deductible donation today. Five years ago, Nancy Skoog-Edholm had no idea that she had two brain aneurysms.
For the new study, Dr. Adeeb and colleagues compared the WEB device in bifurcation and sidewall aneurysms using a large database spanning more than 10 years from the WorldWideWEB consortium, a group ...
LOUISVILLE, KY (WAVE) - It’s no secret that technology has come a long way. Everyday we learn how it can help save and improve lives. There’s a new treatment for brain aneurysms and Norton ...
Terumo Corporation’s (TRUMY) wholly-owned subsidiary MicroVention, Inc. recently announced the publication of the Clinical Evaluation of WEB 17 Device in Intracranial Aneurysms (CLEVER) study results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback